No abstract available
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents / adverse effects*
-
Biomarkers, Tumor / antagonists & inhibitors
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism
-
Female
-
Humans
-
Male
-
Melanoma / drug therapy*
-
Melanoma / enzymology
-
Melanoma / genetics
-
Melanoma / secondary
-
Middle Aged
-
Mutation
-
Platelet Count
-
Protein Kinase Inhibitors / adverse effects*
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
-
Proto-Oncogene Proteins B-raf / genetics
-
Proto-Oncogene Proteins B-raf / metabolism
-
Purpura, Thrombocytopenic, Idiopathic / blood
-
Purpura, Thrombocytopenic, Idiopathic / chemically induced*
-
Purpura, Thrombocytopenic, Idiopathic / diagnosis
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy
-
Purpura, Thrombocytopenic, Idiopathic / immunology
-
Remission Induction
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / enzymology
-
Skin Neoplasms / genetics
-
Skin Neoplasms / pathology
-
Treatment Outcome
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Protein Kinase Inhibitors
-
pembrolizumab
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf